SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly
LLY 1,057+1.5%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Moonray6/10/2020 7:56:25 PM
2 Recommendations

Recommended By
Glenn Petersen
Lance Bredvold

   of 642
 
Eli Lilly could have coronavirus drug ready this fall
Hannah Miller

Eli Lilly could have a drug approved for treating the coronavirus
as early as September, the pharmaceutical company’s chief
scientist told Reuters.

Lilly has launched human trials for two antibody therapies and
is doing pre-clinical studies on a third, Reuters reports. If the
treatments prove effective, they could beat a vaccine to wide-
spread use.

The new therapies are part of a category of medicines called
monoclonal antibodies, which are often used to treat cancer,
rheumatoid arthritis and other conditions.

o~~~ O
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News